The Chorus platform and our founder Armen Arevian, MD PhD were recently featured in the Wall Street Journal
New app tools are being leveraged to help in the treatment of depression, anxiety, and more by providing therapists a stream of information between sessions - and options to intervene if necessary.
The Chorus platform is part of this set of tools, in that leveraging the power of no-code, researchers and clinicians can build their own apps to customize engagement with patients.
How Chorus is leading the next wave of digital health:
"enabling clinicians to respond more quickly to the needs of patients in between visits, predict crises, and help them proactively is much better than looking at apps in isolation and disconnected from human-based in-person care," - Armen Arevian, MD, PhD
Part of the focus of this article was on a study by Dr. Arevian also collaborated with David Miklowitz at UCLA to develop a mobile app for use in a form of family-focused therapy developed by Dr. Miklowitz.
In a pilot test, families used the app at home in addition to virtual or in-person therapy sessions, to practice communication and problem-solving skills. Participants included teens with active symptoms of depression, a parent with a mood disorder and at least one parent who was highly critical of the child.
Mental-health care providers had the app remind the families to work on certain goals, such as having the family practice active-listening skills. The providers also analyzed voice samples from the app, primarily to see what words parents used with their children, as a measure of communication style.
A study published last December in the Journal of Affective Disorders found that after 18 weeks of treatment, participating adolescents reported being less depressed and criticized less frequently by parents, and clinicians reported an improvement in adolescents’ mood symptoms.